Table 4.
Payment modalities for asthma and COPD medicines in African countries
| How is each available medicine paid for by patients | Free (%) | Subsidised (%) | Full out-of-pocket pay (%) | Mixed payment method (%) | Unknown (%) |
|---|---|---|---|---|---|
| Beclometasone HFA inhaler 50 mcg | 18.2 | 22.7 | 40.9 | 18.2 | 0 |
| Beclometasone HFA inhaler 100 mcg | 20.8 | 25.0 | 37.5 | 16.7 | 0 |
| Budesonide inhaler 100 mcg | 16.7 | 16.7 | 50.0 | 17.0 | 0 |
| Budesonide inhaler 200 mcg | 16.7 | 22.2 | 44.4 | 16.7 | 0 |
| Combination inhaler budesonide + formoterol 100/6 | 7.1 | 14.4 | 64.3 | 14.3 | 0 |
| Combination inhaler budesonide + formoterol 200/6 | 7.1 | 14.4 | 64.3 | 14.3 | 0 |
| Adrenaline 1 mg in 1 ml ampoule | 27.3 | 15.2 | 45.5 | 12.1 | 0 |
| Hydrocortisone powder for injection 100 mg in vial | 27.3 | 18.2 | 42.4 | 12.1 | 0 |
| Prednisolone 5 mg tablet | 24.3 | 13.5 | 45.9 | 16.2 | 0 |
| Prednisolone 25 mg | 30.0 | 13.3 | 40.0 | 16.7 | 0 |
| Salbutamol inhaler 100 mcg | 17.1 | 17.1 | 48.6 | 14.3 | 2.9 |
| Salbutamol injection 50 mcg/ml in 5 ml ampoule | 33.3 | 0.0 | 55.6 | 11.1 | 0 |
| Salbutamol metered-dose inhaler 100 mcg | 16.1 | 12.9 | 58.1 | 12.9 | 0 |
| Salbutamol respirator solution for nebulisers 5 mg/ml | 24.1 | 6.9 | 51.7 | 17.2 | 0 |
| Ipratropium bromide inhaler 20 mcg | 6.3 | 12.5 | 68.8 | 12.5 | 0 |
COPD = chronic obstructive pulmonary disease; HFA = hydrofluoroalkane.